US Patent Issued to C4 THERAPEUTICS on Dec. 2 for "Therapeutics for the degradation of mutant BRAF" (Swiss, American, German Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,253, issued on Dec. 2, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.).

"Therapeutics for the degradation of mutant BRAF" was invented by Christopher G. Nasveschuk (Stoneham, Mass.), Katrina L. Jackson (Weston, Mass.), Yanke Liang (Belmont, Mass.), Martin Duplessis (Somerville, Mass.), Mark E. Fitzgerald (Newton, Mass.), Cosimo Dolente (Allschwil, Switzerland), David Stephen Hewings (Basel, Switzerland), Daniel Hunziker (Mohlin, Switzerland), Daniela Krummenacher (Zurich), Piergiorgio Francesco Tommaso Pettazzoni (Regensdorf, Switzerland) and Juergen Wichmann (Steinen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present inventi...